1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Clinical usefulness in geriatric patients of combining CHADS2 and HEMORR2HAGES scores to guide antithrombotic prophylaxis in atrial fibrillation.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Two scores exist to assess the benefits and risks of antithrombotic therapy in patients with atrial fibrillation: CHADS2 [for Congestive heart failure, Hypertension, Age over 75, Diabetes mellitus; and 2 points for a history of Stroke] and HEMORR2HAGES [for Hepatic or renal failure, Ethanol abuse, Malignancy, Older (age over 75), Reduced platelet count or function, 2 points for Rebleeding risk Hypertension (uncontrolled), Anemia, Genetic factors, Excessive fall risk (including neurodegenerative and psychiatric disorders) and history of Stroke]. The potential value of using both scores routinely was studied in order to guide the choice of antithrombotic therapy for geriatric patients.

          Related collections

          Author and article information

          Journal
          Aging Clin Exp Res
          Aging clinical and experimental research
          1594-0667
          1594-0667
          Aug 2010
          : 22
          : 4
          Affiliations
          [1 ] Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Gériatrie, 75908 Paris Cedex 15, France. dominique.somme@egp.aphp.fr
          Article
          6709
          10.3275/6709
          19996707
          e0121125-efd9-4614-a684-e1110e0a4ac5
          History

          Comments

          Comment on this article